How to read a COA for your CBD products
A Certificate of Analysis, or COA, is a laboratory report showing what was found in a tested sample of a CBD product. It can reveal CBD, other cannabinoids and contaminants such as lead, pesticides or residual solvents. That matters because attractive packaging and a percentage on the front do not tell you what is inside the bottle.
Read it as a document for one batch, not a general promise about the brand. A report may be genuine but outdated, issued for a different strength, or supplied for raw material rather than finished gummies. It also cannot establish that a product is approved, safe for every person or effective for a medical condition.
For Australian buyers, the certificate is only part of the assessment. Check the product’s legal status with the Therapeutic Goods Administration, local supply rules and the seller’s claims. The details below show which evidence deserves attention, how to compare different units, and when an impressive-looking report proves very little.
Know what the document proves
A COA should identify the laboratory, sample, methods and findings. Its strongest use is confirming that a particular batch met stated specifications for potency and purity. If the sample came from the end-product, it may also provide useful evidence about the article you received.
Keep its scope narrow. Testing one vial does not verify every bottle or a later production run. A clean report does not make an unapproved product lawful, prove a therapeutic claim or replace a label review. It is analytical evidence, not regulatory endorsement or a guarantee of treatment outcomes.
Match the report to the product
Begin with identity. The product name, form, concentration, pack size and batch number should agree with the bottle. A report for “CBD oil 10%” is not evidence for “sleep gummies 25 mg,” even from the same manufacturer. Check manufacture and expiry or retest dates, plus the date the laboratory received the sample.
Inspect the laboratory details. NATA accreditation in Australia can provide confidence when its scope covers the analyte, method and product matrix; overseas laboratories should show equivalent accreditation. Laboratory accreditation does not mean every listed test is accredited. Method references, technical sign-off, report number and direct contact details make the document verifiable.
Prefer a full PDF or working QR code to a cropped image. Confirm the issuer’s contact details and request the report for your exact batch. A laboratory can authenticate a document, but cannot prove the seller sent the bottle tested. If key identifiers are missing, treat the batch as unverified rather than filling gaps with assumptions.
Decode potency and cannabinoid results
Cannabinoid figures may appear as a percentage, milligrams per gram, milligrams per millilitre or milligrams per unit. Identify whether each number describes the package, a serving or one gummy. “Total CBD” may differ from “CBD per serving” because pack and serving sizes vary. Convert only after confirming the basis.
Check delta-9 THC and total THC, then review other cannabinoids such as CBN, CBG or THC-V. They are not automatically harmless because a label calls them trace amounts. “Not detected” means below the method’s detection or quantitation threshold, not absolute zero, so compare those thresholds between laboratories.
Look for stated pass or fail criteria. An edge value sitting exactly at the limit deserves explanation, while an unexpectedly high total suggests a mismatch between sample, label or batch. A green tick without units, thresholds or acceptance limits gives a consumer little basis for judging the result.
| Report element | Strong evidence | Warning sign |
|---|---|---|
| Product identity | Exact name, strength, form and lot match | Only brand or general strength |
| Timing | Dates align with the product and batch | Old report reused for new stock |
| Cannabinoids | CBD, THC and relevant compounds with units | One unexplained total |
| Purity | Named tests, limits and pass criteria | “100% pure” without analytes |
| Laboratory | Named issuer, accreditation and report number | Logo-only or untraceable file |
Compare gummies without confusing strength with absorption
Gummies need careful serving maths. If a label says 10 mg per gummy and defines a serving as two pieces, that serving contains 20 mg. Five gummies contain 50 mg, not 10 mg. Keep the number of pieces and stated servings per day separate, and do not treat the entire packet as one dose.
Potency describes how much cannabinoid is present; bioavailability concerns how much reaches circulation. A higher milligram number does not automatically mean faster absorption, stronger effects or better value. Our guide to gummy potency and bioavailability explains why formulation, food and individual response complicate label comparisons.
A standard COA does not test human absorption, so it cannot support claims about onset, duration or comparative strength. Compare actual serving directions, gummy count and batch results before choosing. Dose escalation should not be based on a marketing comparison alone.
Look for a credible purity panel
Purity testing should address risks relevant to cannabis products. Depending on the product and process, look for heavy metals such as lead, arsenic, cadmium and mercury; pesticide residues; residual solvents; microbial contamination; and mycotoxins. State each test, result, reporting limit and acceptance criterion. “Heavy metal free” without analyte names is a slogan, not laboratory evidence.
Read the method as well as the outcome. A laboratory may use HPLC or mass spectrometry, but the method must suit the sample and analyte. Check that accreditation covers that method and that its reporting limit makes a “pass” meaningful. A panel limited to CBD and THC cannot support claims of a clean, solvent-free product.
Be cautious with partial reports. A certificate listing cannabinoids but omitting pesticide, solvent and microbial tests may be all that was commissioned, yet it cannot support broader purity claims. Check the date, because results are batch-specific and reformulations need fresh documents. Never rely on a generic certificate at the bottom of a webpage.
Check Australian legality and marketing claims
Federal rules administered by the TGA distinguish ARTG-listed therapeutic goods from products supplied under specific routes, including a low-dose route capped at 100 mg of CBD per day. Qualifying low-dose products may be supplied without prior TGA approval, but must meet applicable ingredient, quality, labelling and advertising requirements. Higher-dose or compounded CBD generally relies on an authorised prescribing and pharmacy pathway.
State and territory rules can add restrictions, and imported gummies sold as food or supplements overseas may not be lawful to supply here. An Australian-dollar price or local return address does not change that. Shoppers in Sydney, Melbourne or Brisbane can encounter different retail arrangements, so check the relevant jurisdiction and search the ARTG when a medicinal product is claimed. A COA cannot cure an unlawful supply.
Separate advertising claims from laboratory findings. A certificate may confirm a stated CBD quantity; it says nothing about stress relief, pain treatment, sleep outcomes or cholesterol. Our discussion of keto supplements and cholesterol shows the same distinction between ingredient evidence and promised outcomes. Misleading representations can breach the Australian Consumer Law, while consumer guarantees may provide a remedy when goods fail to match their description or purpose.
Keep records and make a final batch check
Save the COA, label, receipt and batch number together, preferably on your phone before ordering a replacement. When a new bottle arrives, compare its lot with the stored report and look for updated testing. If results changed, ask why rather than assuming the later document is better. This is particularly useful with online and marketplace purchases.
Use the evidence with appropriate health caution. CBD may cause drowsiness and can interact with some medicines, including anticoagulants and drugs processed by the liver. A pharmacist or doctor can assess suitability if you take regular medication, are pregnant or breastfeeding, or have a liver condition. Keep products away from children and pets and follow the label.
A defensible purchase has matching identifiers, current batch results, a credible purity panel and a clear legal basis for supply in Australia. If an element fails, contact the seller or manufacturer and retain the records. For suspected adverse effects, give a health professional the batch details; Australia’s Poison Information Centre is available on 13 11 26, while Healthdirect’s nurse service is 1800 022 222.